Clinical Trial Update: PRecisiOn Microbiome Directed ExtensiOn of Anti-TNFα Crohn's Disease ThErapy in Children: The PROMOTE Trial [NA]

View source ↗

Summary

The PROMOTE trial investigates a precision, microbiome-directed extension of anti-TNFα therapy for pediatric Crohn's disease; the study is currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: Children's Hospital of Eastern Ontario | Conditions: Inflammatory Bowel Diseases, Crohn Disease | NA | Status: ACTIVE_NOT_RECRUITING